Inclusion of both the uPA/PAI-1 and Ki67 criteria increased the rate of identification of tumours with a high risk of recurrence (and thus with a potential indication for adjuvant chemotherapy) by 20% (P < 0.001) compared with using the St. This evidence concerns the gene MKI67 and neoplasm.